keyword
MENU ▼
Read by QxMD icon Read
search

Ribomustin

keyword
https://www.readbyqxmd.com/read/26507499/is-there-hope-to-treat-glioblastoma-effectively
#1
Thomas Mehrling, Roshaine Gunawardana
Thomas Mehrling was appointed Managing Director of Mundipharma EDO GmbH, Basel, in January 2013 and brings extensive experience with more than 17 years in the industry to this role. During his career, he has held various senior positions in different companies across almost all functions in drug development and commercialization. Most recently, he held the position of International Director Oncology Strategy (2011-2013). From 2004 to 2011 he served as European Director Oncology at Mundipharma International Ltd...
2015: CNS Oncology
https://www.readbyqxmd.com/read/21695099/bendamustine-safety-and-efficacy-in-the-management-of-indolent-non-hodgkins-lymphoma
#2
Nishant Tageja
Bendamustine (Treanda, Ribomustin) was recently approved by the US Food and Drug Administration (FDA) for treatment of patients with rituximab refractory indolent lymphoma and is expected to turn into a frontline therapy option for indolent lymphoma. This compound with amphoteric properties was designed in the former Germany Democratic Republic in 1960s and re-discovered in 1990s with multiple successive well-designed studies. Bendamustine possesses a unique mechanism of action with potential antimetabolite properties, and only partial cross-resistance with other alkylators...
2011: Clinical Medicine Insights. Oncology
https://www.readbyqxmd.com/read/20376452/bendamustine-something-old-something-new
#3
REVIEW
Nishant Tageja, Jasdeepa Nagi
BACKGROUND: Bendamustine (Treanda, Ribomustin) is a water-soluble, bifunctional chemotherapeutic agent that also has potential antimetabolite properties and only partial cross-resistance with other alkylators. Designed in 1963 and re-discovered in 1990s, this drug's unique mechanism of action and favorable side-effect profile promise a major role in the management of lymphoproliferative disorders. Bendamustine has been designated as an orphan drug in the United States, conferring prolonged market exclusivity...
August 2010: Cancer Chemotherapy and Pharmacology
https://www.readbyqxmd.com/read/20110042/bendamustine-for-the-treatment-of-chronic-lymphocytic-leukemia-and-rituximab-refractory-indolent-b-cell-non-hodgkin-lymphoma
#4
REVIEW
Trevor W Dennie, Jill M Kolesar
BACKGROUND: Bendamustine is a mechlorethamine derivative with a purine-like benzimidazole ring, which may enhance its clinical efficacy. Bendamustine was approved by the US Food and Drug Administration (FDA) for the treatment of chronic lymphocytic leukemia (CLL) in March 2008 and for the treatment of rituximab-refractory, indolent B-cell non-Hodgkin lymphoma (NHL) in October 2008. OBJECTIVE: This article reviews the pharmacologic and pharmacodynamic properties of bendamustine, together with data on efficacy and toxicity from trials investigating the use of bendamustine for the treatment of various hematologic malignancies, including CLL, NHL, and multiple myeloma (MM)...
2009: Clinical Therapeutics
https://www.readbyqxmd.com/read/19649333/bendamustine-hydrochloride-a-renaissance-of-alkylating-strategies-in-anticancer-medicine
#5
M Eichbaum, E Bischofs, K Nehls, A Schneeweiss, C Sohn
Alkylating drugs represent one of the oldest classes of anticancer medicine used in a broad variety of clinical indications. Bendamustine hydrochloride (Ribomustine, Treanda) is a newer alkylating agent which has already been under intensive clinical investigation and has gained emerging interest due to its unique pharmacological properties, particularly in resistant or refractory diseases. This article provides basic information on the molecular mechanisms of action of bendamustine and its pharmacological characteristics and an overview on published clinical trials where bendamustine is analyzed as a single agent as well as in combination therapies for the treatment of solid tumors and hematologic malignancies...
June 2009: Drugs of Today
https://www.readbyqxmd.com/read/19093705/bendamustine-a-review-of-its-use-in-the-management-of-indolent-non-hodgkin-lymphoma
#6
REVIEW
Greg L Plosker, Natalie J Carter
Bendamustine (Treanda, Ribomustin) is a bifunctional alkylating agent that also has potential antimetabolite properties, and only partial cross-resistance occurs between bendamustine and other alkylators. In patients with indolent non-Hodgkin lymphoma (NHL), bendamustine monotherapy achieved high objective response rates in those with rituximab-refractory disease in a pivotal noncomparative trial and a similarly designed smaller phase II study. Many of these heavily treated patients were also refractory to standard chemotherapy regimens...
2008: Drugs
https://www.readbyqxmd.com/read/12170425/metabolism-and-mechanisms-of-action-of-bendamustine-rationales-for-combination-therapies
#7
REVIEW
Varsha Gandhi
Bendamustine hydrochloride is the active ingredient of Ribomustin (Ribosepharm GmbH, Munich, Germany). It was first synthesized in 1963 in the German Democratic Republic. Bendamustine is chemically related to the alkylating agent chlorambucil, with the benzene ring in the chlorambucil molecule replaced by a 1-methyl-benzimidazole moiety. The mechanisms of action of bendamustine have been under investigation since the early 1960s, and its first use was as a treatment for multiple myeloma in 1969. Bendamustine has three active moieties: an alkylating group, in common with the nitrogen mustard family; a benzimidazole ring, which may act as a purine analog; and a butyric acid side-chain...
August 2002: Seminars in Oncology
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"